Aisling Capital Management »

Vtv Therapeutics Inc Cl A shares owned by Aisling Capital Management

Quarter-by-quarter ownership of Vtv Therapeutics Inc Cl A (VTVT) shares owned by Aisling Capital Management from 13F filings

Historical chart of Aisling Capital Management investment in Vtv Therapeutics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Vtv Therapeutics Inc Cl A held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vtv Therapeutics Inc Cl A by Aisling Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 50k 37.65

More positions owned by Aisling Capital Management

Bridgebio Pharma (BBIO)
Monte Rosa Therapeutics (GLUE)
Syndax Pharmaceuticals (SNDX)
Compass Pathways Sponsored Ads (CMPS)
Bicara Therapeutics (BCAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Scholar Rock Hldg Corp (SRRK)
Urogen Pharma (URGN)
Biomea Fusion (BMEA)
Aclaris Therapeutics (ACRS)
Eupraxia Pharmaceuticals (EPRX)
Vtv Therapeutics Cl A New (VTVT)
Marker Therapeutics Com New (MRKR)
Onkure Therapeutics Com Cl A (OKUR)

View all positions for Aisling Capital Management

Top funds holding Vtv Therapeutics Inc Cl A

Samsara BioCapital
Millennium Management
FMR
Siren
Baker Bros. Advisors
Vanguard Capital Management
Trails Edge Capital Partners
Aisling Capital Management
Marshall Wace
Geode Capital Management
Renaissance Technologies
Vanguard Fiduciary Trust
BlackRock
Jane Street
Two Sigma Investments

View all funds holding Vtv Therapeutics Inc Cl A